- Home
- PUMP vs DNTH Comparison
PUMP vs DNTH Comparison
Compare PUMP & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PUMP
- DNTH
- Stock Information
- Founded
- PUMP 2007
- DNTH 2015
- Country
- PUMP United States
- DNTH United States
- Employees
- PUMP N/A
- DNTH N/A
- Industry
- PUMP Oilfield Services/Equipment
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- PUMP Energy
- DNTH Health Care
- Exchange
- PUMP Nasdaq
- DNTH Nasdaq
- Market Cap
- PUMP 634.9M
- DNTH 651.8M
- IPO Year
- PUMP 2017
- DNTH N/A
- Fundamental
- Price
- PUMP $4.92
- DNTH $24.30
- Analyst Decision
- PUMP Buy
- DNTH Strong Buy
- Analyst Count
- PUMP 6
- DNTH 8
- Target Price
- PUMP $8.80
- DNTH $54.00
- AVG Volume (30 Days)
- PUMP 2.4M
- DNTH 362.9K
- Earning Date
- PUMP 07-30-2025
- DNTH 08-07-2025
- Dividend Yield
- PUMP N/A
- DNTH N/A
- EPS Growth
- PUMP N/A
- DNTH N/A
- EPS
- PUMP N/A
- DNTH N/A
- Revenue
- PUMP $1,366,989,000.00
- DNTH $4,854,000.00
- Revenue This Year
- PUMP N/A
- DNTH N/A
- Revenue Next Year
- PUMP $9.57
- DNTH N/A
- P/E Ratio
- PUMP N/A
- DNTH N/A
- Revenue Growth
- PUMP N/A
- DNTH 17.87
- 52 Week Low
- PUMP $4.51
- DNTH $13.37
- 52 Week High
- PUMP $11.17
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- PUMP 44.11
- DNTH 69.50
- Support Level
- PUMP $4.51
- DNTH $19.84
- Resistance Level
- PUMP $4.97
- DNTH $21.18
- Average True Range (ATR)
- PUMP 0.27
- DNTH 1.58
- MACD
- PUMP 0.02
- DNTH 0.39
- Stochastic Oscillator
- PUMP 51.25
- DNTH 89.88
About PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.